Commentary: current perspectives on the aggregation of protein drugs

about

Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.

P2860

Q38841187-EA776AE7-2F00-424B-9CCE-9EFB08572939

P2860

Commentary: current perspectives on the aggregation of protein drugs

Item

http://www.wikidata.org/entity/Q39302610

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Commentary: current perspectives on the aggregation of protein drugs

@en

Commentary: current perspectives on the aggregation of protein drugs.

@nl

type

Item

label

Commentary: current perspectives on the aggregation of protein drugs

@en

Commentary: current perspectives on the aggregation of protein drugs.

@nl

prefLabel

Commentary: current perspectives on the aggregation of protein drugs

@en

Commentary: current perspectives on the aggregation of protein drugs.

@nl

P1476

Commentary: current perspectives on the aggregation of protein drugs

@en

P2093

Elizabeth M Topp

http://www.w3.org/2001/XMLSchema#string

P2860

Aggregation and pH-temperature phase behavior for aggregates of an IgG2 antibody.

High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Non-Arrhenius protein aggregation.

Comparability assessments of process and product changes made during development of two different monoclonal antibodies.

Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.

An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.

Slip flow in colloidal crystals for ultraefficient chromatography.

Silica colloidal crystals as emerging materials for high-throughput protein electrophoresis.

Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA.

Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.

P2888

s12248-014-9580-0

P304

413-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12248-014-9580-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051913743

http://www.w3.org/2001/XMLSchema#string

P698

24563118

http://www.w3.org/2001/XMLSchema#string

P932

4012046

http://www.w3.org/2001/XMLSchema#string

Commentary: current perspectives on the aggregation of protein drugs

about

P2860

P2860

Commentary: current perspectives on the aggregation of protein drugs

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932